Arcturus

ARCT NASDAQ
10.90
+0.59
+5.72%
Closed 16:00 08/22 EDT
Open
10.32
Prev Close
10.31
High
10.99
Low
9.88
Volume
50.74K
Avg Vol (3M)
85.99K
52 Week High
15.50
52 Week Low
4.110
% Turnover
0.47%
Market Cap
116.84M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Arcturus ARCT stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Arcturus Therapeutics Ltd. is a ribonucleic acid (RNA) medicines company. The Company owns Lipid-enabled and Unlocked Nucleomonomer Agent modified RNA (LUNAR) lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology, including UNA Oligomers. The Company’s diverse pipeline of RNA therapeutics includes programs pursuing rare diseases, Hepatitis B, non-alcoholic steatohepatitis (NASH), cystic fibrosis and vaccines. The Company’s versatile RNA therapeutics platforms can be applied toward multiple types of RNA medicines, including small interfering RNA, messenger RNA, replicon RNA, antisense RNA, microRNA and gene editing therapeutics. The Company's UNA technology can be used to target individual genes in the human genome, as well as viral genes, and other species for therapeutic purposes.
MORE >

Recently

Name
Price
%Change